SMTL ID : 5lo1.1

HSP90 WITH indazole derivative

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 70L: 1-[2-Amino-4-(1,3-dihydro-isoindole-2-carbonyl)-quinazolin-6-yl]-cyclobutanecarboxylic acid ethylamide(Non-covalent)

70L.1: 16 residues within 4Å: Chain A: N.44, D.47, A.48, K.51, D.86, I.89, G.90, M.91, D.95, L.100, I.103, F.131, Y.132, V.143, W.155, T.177 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:D.47, A:A.48, A:K.51, A:I.89, A:D.95, A:L.100, A:L.100, A:I.103, A:F.131, A:V.143 Hydrogen bonds: A:K.51, A:T.177, A:T.177 Water bridges: A:N.44, A:T.177, A:T.177 Salt bridges: A:D.86 pi-Stacking: A:F.131, A:W.155, A:W.155

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schuetz, D.A. et al., Ligand Desolvation Steers On-Rate and Impacts Drug Residence Time of Heat Shock Protein 90 (Hsp90) Inhibitors. J. Med. Chem. (2018)

Release Date

2017-11-29

Peptides

Heat shock protein HSP 90-alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Heat shock protein HSP 90-alpha

Related Entries With Identical Sequence